The #CCTG ME17 clinical trial will investigate fecal microbiota transplantation with immune checkpoint blockade compared to immune checkpoint blockade alone in patients with advanced #Melanoma #SolvingCancerTogether
An estimated 11,300 Canadians are expected to be diagnosed with melanoma this year. That’s why we are proud to be uniting with a team of 12 researchers and collaborators to lead one of the world’s largest randomized clinical trials using fecal microbiota transplantation to improve the effectiveness of treatments for advanced melanoma. ▶️ Discover how this promising treatment has already changed the lives of people facing cancer. Visit the link below to learn more. https://lnkd.in/eEP8JREW #MelanomaSkinCancerAwarenessMonth #Melanoma Centre de recherche du CHUM (CRCHUM) CHUM - Centre hospitalier de l'Université de Montréal Dr. Arielle Elkrief MD, FRCPC Bertrand Routy Rahima Jamal Weston Family Foundation Lawson Health Research Institute Canadian Cancer Trials Group